Status:

COMPLETED

Treatment With the Specific Carbohydrate Diet for Children With Active Crohns Disease and Ulcerative Colitis

Lead Sponsor:

David Suskind

Conditions:

Crohn's Disease

Ulcerative Colitis

Eligibility:

All Genders

8-21 years

Phase:

NA

Brief Summary

The aim of this study is to determine the tolerability and potential efficacy of dietary therapy, the Specific Carbohydrate Diet (SCD), in pediatric patients with Crohn's disease (CD) and Ulcerative C...

Detailed Description

Ten patients with CD or UC with mild or moderate disease activity as defined by Pediatric Crohn's disease activity index (PCDAI score of 10-29 or PUCAI of 10 - 60) aged 8 -21 years will enroll into th...

Eligibility Criteria

Inclusion

  • Children and adolescents eight to twenty one years old
  • Diagnosis of Ulcerative colitis or Crohn's Disease made by a primary gastroenterologist based upon history, physical exam, laboratory/radiological studies and gastrointestinal histology
  • Mild or moderate disease activity based upon PCDAI score (10-45) or PUCAI score (10-60)
  • Parent/guardian and child must be able to comprehend the consent and assent
  • Parent/guardian and participant must be able to attend study visits at baseline, and weeks +2, +4, +8, +12.
  • Patient must not have medication changes for his/her inflammatory bowel disease medications for at least 1 months, unless medically necessary.

Exclusion

  • Severe disease with PCDAI \>45 or PUCAI \>60
  • Active or history of intraabdominal abscess, intraabdominal fistula, stricturing Crohn's disease
  • Other serious medical conditions such as neurological, liver, kidney, autoimmune or systemic disease.
  • Has begun TNF inhibitors within two months prior to study
  • Has had change of maintenance medication within the last month
  • Tobacco, alcohol or illicit drug abuse
  • Pregnant subject recipients will be excluded

Key Trial Info

Start Date :

June 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2017

Estimated Enrollment :

9 Patients enrolled

Trial Details

Trial ID

NCT02213835

Start Date

June 1 2014

End Date

September 1 2017

Last Update

May 24 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seattle Children's Hospital

Seattle, Washington, United States, 98105